Press Statements

Archives: Search / 2020 / 2019 / 2017 / 2016 / 2015 / 2013

2017 Archives

Dec 19, 2017
Voluntary Recall of Synvisc-One Lot 7RSL021
Oct 6, 2017
Sanofi Pasteur Closes Emergent Acquisition of Smallpox Vaccine
Sep 1, 2017
Sanofi Statement on Zika Vaccine License
Jul 24, 2017
Kathleen Tregoning Letter to the Editor Regarding Accessibility of Medicines
Jul 24, 2017
Kathleen Tregoning Letter to the Editor Regarding Accessibility of Medicines
Jul 16, 2017
Sanofi Response to U.S. Senators Regarding Investigational Zika Vaccine
Jul 14, 2017
Sanofi Scientists Discuss Investigational Zika Vaccine
Jul 14, 2017
Sanofi Response to U.S. Senators Regarding Investigational Zika Vaccine
Jul 14, 2017
Sanofi Letter to U.S. Army on Developing a Zika Vaccine
Jul 12, 2017
Sanofi Letter to U.S. Army on Developing a Zika Vaccine
Jun 27, 2017
Elias Zerhouni Letter to the Editor Regarding Developing a Zika Vaccine
May 25, 2017
Sanofi Letter Submitted to the Energy and Commerce Oversight Hearing on Zika
Mar 21, 2017
Elias Zerhouni Letter to the Editor Regarding Developing a Zika Vaccine
Feb 9, 2017
Sanofi Pasteur Commends the CDC for Updates Made to the 2017 Children and Adolescent Immunization Schedule
Feb 9, 2017
Sanofi Pasteur Statement on the Discontinuation of Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined
Jan 13, 2017
Sanofi and Regeneron File Notice of Appeal and Motion to Stay (Suspend) Injunction with Federal Circuit Court of Appeals in Patent Case Regarding Praluent® (alirocumab) Injection
Jan 9, 2017
Sanofi and Regeneron Provide Update on Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection